Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2008, Vol.372 (9638)
Main Authors: SARAFIDIS, Pantelis A, BAKRIS, George L, BUDAJ, Andrzej, CHAITHIRAPHAN, Suphachai, DICKSTEIN, Kenneth, KELTAI, Matyas, METSARINNE, Kaj, OTO, All, PARKHOMENKO, Alexander, PIEGAS, Leopoldo S, SVENDSEN, Tage L, TEO, Koon K, MANN, Johannes F. E, YUSUF, Salim, SCHMIEDER, Roland E, MCQUEEN, Matthew, DYAL, Leanne, SCHUMACHER, Helmut, POGUE, Janice, XINGYU WANG, MAGGIONI, Aldo
Format: Article
Language:English
Subjects:
Biological and medical sciences
General aspects
Medical sciences
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 9638
container_start_page
container_title The Lancet (British edition)
container_volume 372
creator SARAFIDIS, Pantelis A
BAKRIS, George L
BUDAJ, Andrzej
CHAITHIRAPHAN, Suphachai
DICKSTEIN, Kenneth
KELTAI, Matyas
METSARINNE, Kaj
OTO, All
PARKHOMENKO, Alexander
PIEGAS, Leopoldo S
SVENDSEN, Tage L
TEO, Koon K
MANN, Johannes F. E
YUSUF, Salim
SCHMIEDER, Roland E
MCQUEEN, Matthew
DYAL, Leanne
SCHUMACHER, Helmut
POGUE, Janice
XINGYU WANG
MAGGIONI, Aldo
description
format article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_20558141</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20558141</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_205581413</originalsourceid><addsrcrecordid>eNqNjs1KxDAUhYMoWEff4W4EhVZSJ23FnQyjrhSGLmY33LZ3bPQmKUmqzFv5iEbwAVwdDnzn50hkpWpUUalmeywyWSpZ1M2yPhVnIbxLKVUtq0x8b8gig5tj7wwF-NJxhEhsdEAf0ebg0ejJa87BeehcHHPQFiZyExNghFG_jfCJoZ8ZPXgdPuAqjgSvL-3D5mndQojzcLiGe0AwM0fdk42efovt4NIODTkMbu6Yio61Ta53iXDMNED0GvkGVs6YFEN_OBcne-RAF3-6EJeP63b1XEzpAvI-tfY67NJjk-jdrayqu1KVy_9yP3JcZFc</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary</title><source>ScienceDirect Freedom Collection</source><creator>SARAFIDIS, Pantelis A ; BAKRIS, George L ; BUDAJ, Andrzej ; CHAITHIRAPHAN, Suphachai ; DICKSTEIN, Kenneth ; KELTAI, Matyas ; METSARINNE, Kaj ; OTO, All ; PARKHOMENKO, Alexander ; PIEGAS, Leopoldo S ; SVENDSEN, Tage L ; TEO, Koon K ; MANN, Johannes F. E ; YUSUF, Salim ; SCHMIEDER, Roland E ; MCQUEEN, Matthew ; DYAL, Leanne ; SCHUMACHER, Helmut ; POGUE, Janice ; XINGYU WANG ; MAGGIONI, Aldo</creator><creatorcontrib>SARAFIDIS, Pantelis A ; BAKRIS, George L ; BUDAJ, Andrzej ; CHAITHIRAPHAN, Suphachai ; DICKSTEIN, Kenneth ; KELTAI, Matyas ; METSARINNE, Kaj ; OTO, All ; PARKHOMENKO, Alexander ; PIEGAS, Leopoldo S ; SVENDSEN, Tage L ; TEO, Koon K ; MANN, Johannes F. E ; YUSUF, Salim ; SCHMIEDER, Roland E ; MCQUEEN, Matthew ; DYAL, Leanne ; SCHUMACHER, Helmut ; POGUE, Janice ; XINGYU WANG ; MAGGIONI, Aldo</creatorcontrib><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Lancet</publisher><subject>Biological and medical sciences ; General aspects ; Medical sciences</subject><ispartof>The Lancet (British edition), 2008, Vol.372 (9638)</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4009</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20558141$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>SARAFIDIS, Pantelis A</creatorcontrib><creatorcontrib>BAKRIS, George L</creatorcontrib><creatorcontrib>BUDAJ, Andrzej</creatorcontrib><creatorcontrib>CHAITHIRAPHAN, Suphachai</creatorcontrib><creatorcontrib>DICKSTEIN, Kenneth</creatorcontrib><creatorcontrib>KELTAI, Matyas</creatorcontrib><creatorcontrib>METSARINNE, Kaj</creatorcontrib><creatorcontrib>OTO, All</creatorcontrib><creatorcontrib>PARKHOMENKO, Alexander</creatorcontrib><creatorcontrib>PIEGAS, Leopoldo S</creatorcontrib><creatorcontrib>SVENDSEN, Tage L</creatorcontrib><creatorcontrib>TEO, Koon K</creatorcontrib><creatorcontrib>MANN, Johannes F. E</creatorcontrib><creatorcontrib>YUSUF, Salim</creatorcontrib><creatorcontrib>SCHMIEDER, Roland E</creatorcontrib><creatorcontrib>MCQUEEN, Matthew</creatorcontrib><creatorcontrib>DYAL, Leanne</creatorcontrib><creatorcontrib>SCHUMACHER, Helmut</creatorcontrib><creatorcontrib>POGUE, Janice</creatorcontrib><creatorcontrib>XINGYU WANG</creatorcontrib><creatorcontrib>MAGGIONI, Aldo</creatorcontrib><title>Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary</title><title>The Lancet (British edition)</title><subject>Biological and medical sciences</subject><subject>General aspects</subject><subject>Medical sciences</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqNjs1KxDAUhYMoWEff4W4EhVZSJ23FnQyjrhSGLmY33LZ3bPQmKUmqzFv5iEbwAVwdDnzn50hkpWpUUalmeywyWSpZ1M2yPhVnIbxLKVUtq0x8b8gig5tj7wwF-NJxhEhsdEAf0ebg0ejJa87BeehcHHPQFiZyExNghFG_jfCJoZ8ZPXgdPuAqjgSvL-3D5mndQojzcLiGe0AwM0fdk42efovt4NIODTkMbu6Yio61Ta53iXDMNED0GvkGVs6YFEN_OBcne-RAF3-6EJeP63b1XEzpAvI-tfY67NJjk-jdrayqu1KVy_9yP3JcZFc</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>SARAFIDIS, Pantelis A</creator><creator>BAKRIS, George L</creator><creator>BUDAJ, Andrzej</creator><creator>CHAITHIRAPHAN, Suphachai</creator><creator>DICKSTEIN, Kenneth</creator><creator>KELTAI, Matyas</creator><creator>METSARINNE, Kaj</creator><creator>OTO, All</creator><creator>PARKHOMENKO, Alexander</creator><creator>PIEGAS, Leopoldo S</creator><creator>SVENDSEN, Tage L</creator><creator>TEO, Koon K</creator><creator>MANN, Johannes F. E</creator><creator>YUSUF, Salim</creator><creator>SCHMIEDER, Roland E</creator><creator>MCQUEEN, Matthew</creator><creator>DYAL, Leanne</creator><creator>SCHUMACHER, Helmut</creator><creator>POGUE, Janice</creator><creator>XINGYU WANG</creator><creator>MAGGIONI, Aldo</creator><general>Lancet</general><scope>IQODW</scope></search><sort><creationdate>2008</creationdate><title>Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary</title><author>SARAFIDIS, Pantelis A ; BAKRIS, George L ; BUDAJ, Andrzej ; CHAITHIRAPHAN, Suphachai ; DICKSTEIN, Kenneth ; KELTAI, Matyas ; METSARINNE, Kaj ; OTO, All ; PARKHOMENKO, Alexander ; PIEGAS, Leopoldo S ; SVENDSEN, Tage L ; TEO, Koon K ; MANN, Johannes F. E ; YUSUF, Salim ; SCHMIEDER, Roland E ; MCQUEEN, Matthew ; DYAL, Leanne ; SCHUMACHER, Helmut ; POGUE, Janice ; XINGYU WANG ; MAGGIONI, Aldo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_205581413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biological and medical sciences</topic><topic>General aspects</topic><topic>Medical sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SARAFIDIS, Pantelis A</creatorcontrib><creatorcontrib>BAKRIS, George L</creatorcontrib><creatorcontrib>BUDAJ, Andrzej</creatorcontrib><creatorcontrib>CHAITHIRAPHAN, Suphachai</creatorcontrib><creatorcontrib>DICKSTEIN, Kenneth</creatorcontrib><creatorcontrib>KELTAI, Matyas</creatorcontrib><creatorcontrib>METSARINNE, Kaj</creatorcontrib><creatorcontrib>OTO, All</creatorcontrib><creatorcontrib>PARKHOMENKO, Alexander</creatorcontrib><creatorcontrib>PIEGAS, Leopoldo S</creatorcontrib><creatorcontrib>SVENDSEN, Tage L</creatorcontrib><creatorcontrib>TEO, Koon K</creatorcontrib><creatorcontrib>MANN, Johannes F. E</creatorcontrib><creatorcontrib>YUSUF, Salim</creatorcontrib><creatorcontrib>SCHMIEDER, Roland E</creatorcontrib><creatorcontrib>MCQUEEN, Matthew</creatorcontrib><creatorcontrib>DYAL, Leanne</creatorcontrib><creatorcontrib>SCHUMACHER, Helmut</creatorcontrib><creatorcontrib>POGUE, Janice</creatorcontrib><creatorcontrib>XINGYU WANG</creatorcontrib><creatorcontrib>MAGGIONI, Aldo</creatorcontrib><collection>Pascal-Francis</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SARAFIDIS, Pantelis A</au><au>BAKRIS, George L</au><au>BUDAJ, Andrzej</au><au>CHAITHIRAPHAN, Suphachai</au><au>DICKSTEIN, Kenneth</au><au>KELTAI, Matyas</au><au>METSARINNE, Kaj</au><au>OTO, All</au><au>PARKHOMENKO, Alexander</au><au>PIEGAS, Leopoldo S</au><au>SVENDSEN, Tage L</au><au>TEO, Koon K</au><au>MANN, Johannes F. E</au><au>YUSUF, Salim</au><au>SCHMIEDER, Roland E</au><au>MCQUEEN, Matthew</au><au>DYAL, Leanne</au><au>SCHUMACHER, Helmut</au><au>POGUE, Janice</au><au>XINGYU WANG</au><au>MAGGIONI, Aldo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary</atitle><jtitle>The Lancet (British edition)</jtitle><date>2008</date><risdate>2008</risdate><volume>372</volume><issue>9638</issue><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><cop>London</cop><pub>Lancet</pub></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 2008, Vol.372 (9638)
issn 0140-6736
1474-547X
language eng
recordid cdi_pascalfrancis_primary_20558141
source ScienceDirect Freedom Collection
subjects Biological and medical sciences
General aspects
Medical sciences
title Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A30%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Renal%20outcomes%20with%20telmisartan,%20ramipril,%20or%20both,%20in%20people%20at%20high%20vascular%20risk%20(the%20ONTARGET%20study)%20:%20a%20multicentre,%20randomised,%20double-blind,%20controlled%20trial.%20Commentary&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=SARAFIDIS,%20Pantelis%20A&rft.date=2008&rft.volume=372&rft.issue=9638&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E20558141%3C/pascalfrancis%3E%3Cgrp_id%3Ecdi_FETCH-pascalfrancis_primary_205581413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true